Pathos is a clinical-stage biotechnology company focused on precision oncology. It is building a next-generation drug development engine that integrates artificial intelligence, biological modelling, and what it describes as the largest collection of oncology patient data. The platform aims to make clinical trials smarter, faster, and more precise by deploying thousands of AI agents to analyse data, simulate trial scenarios, and identify responsive patient populations.
The company's data collection spans millions of oncology records, incorporating genomics, transcriptomics, imaging, text, and longitudinal clinical outcomes. Its technical domains include AI, biological modelling, data science, oncology informatics, and clinical trial simulation.
Pathos operates with a model in which small teams of subject-matter experts direct hundreds of AI agents to execute work at scale. The company sits at the intersection of biotechnology, oncology, pharmaceuticals, and clinical research.
